ChemicalBook > CAS DataBase List > DOTA-NOC, DOTA-[Nal3]-octreotide

DOTA-NOC, DOTA-[Nal3]-octreotide

Product Name
DOTA-NOC, DOTA-[Nal3]-octreotide
CAS No.
619300-53-7
Chemical Name
DOTA-NOC, DOTA-[Nal3]-octreotide
Synonyms
FC-2154;DOTA-NOC;DOTA-NOC acetate;DOTA-NOC619300-53-7;DOTA-[Nal3]-octreotide;DOTA-NOC, DOTA-[Nal3]-octreotide;L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-Dtryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic(2)-disulfide;L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2-7)-disulfide;L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide;2-[[10-(4-aminobutyl)-7-(1-hydroxyethyl)-13-(1~{H}-indol-3-ylmethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-19-[[3-phenyl-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoic acid
CBNumber
CB11484181
Molecular Formula
C69H92N14O18S2
Formula Weight
1469.68178
MOL File
619300-53-7.mol
More
Less

DOTA-NOC, DOTA-[Nal3]-octreotide Property

CAS DataBase Reference
619300-53-7
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

DOTA-NOC, DOTA-[Nal3]-octreotide Chemical Properties,Usage,Production

Chemical Properties

Colourless to off-white lyophilised solid

DOTA-NOC, DOTA-[Nal3]-octreotide Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

DOTA-NOC, DOTA-[Nal3]-octreotide Suppliers

619300-53-7, DOTA-NOC, DOTA-[Nal3]-octreotideRelated Search:


  • DOTA-NOC
  • DOTA-NOC acetate
  • L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-Dtryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic(2)-disulfide
  • DOTA-NOC619300-53-7
  • DOTA-NOC, DOTA-[Nal3]-octreotide
  • L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2-7)-disulfide
  • DOTA-[Nal3]-octreotide
  • 2-[[10-(4-aminobutyl)-7-(1-hydroxyethyl)-13-(1~{H}-indol-3-ylmethyl)-16-(naphthalen-1-ylmethyl)-6,9,12,15,18-pentaoxo-19-[[3-phenyl-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoic acid
  • FC-2154
  • L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
  • 619300-53-7
  • C69H94N14O17S2
  • C69H92N14O18S2